The deprescribing.org Blog
Follow the latest blog posts on deprescribing topics
On the Blog
Welcome to the first and best (well, the only) deprescribing blog on the internet, hosted by pharmacists and postdoctoral researchers, Carina Lundby and Wade Thompson. We hope to be your new best deprescribing friends and supply you with deprescribing content and analysis on a biweekly basis. Please reach out to us if you have any questions or comments, or would like to contribute (carina.lundby.olesen@rsyd.dk, wthompson@health.sdu.dk).
Interview #5: Deprescribing in telemedicine
Hello, deprescribers! Today we are excited to have another interview post with clinical pharmacist Pam Howell (Ontario, Canada), telling us about her (deprescribing) experiences working as part of the telemedicine initiative GeriMedRisk. Q: You are part...
Interview #4: Development of a Dutch deprescribing guideline
Hello, deprescribers! Today we have another interview blog post with Dr. Petra Denig, Professor at the University of Groningen, telling us about the development of deprescribing recommendations for the Dutch multidisciplinary guideline on polypharmacy in older people....
Interview #3: Deprescribing experiences from a virtual pharmacology outpatient clinic in Denmark
Hello, deprescribers! Today we have another interview blog post with Daniel Pilsgaard Henriksen, Clinical Pharmacologist at Odense University Hospital and Associate Professor at University of Southern Denmark, telling about his experiences with deprescribing in a...
Guest Blog Post #12: Protecting the human right to try: Evidence-based deprescription of antipsychotic medication
Hello, deprescribing world. Today we have Dr. Helene Speyer, MD, Ph.D. at Mental Health Center Copenhagen (Denmark), telling us about an ongoing project on deprescribing of antipsychotics. Take it away, Helene! “When can I get off this medication?” Most people taking...
Guest Blog Post #11: Deprescribing experiences from a primary care pharmacist
Welcome to another guest blog post. Today we have Cynthia Leung, pharmacist at the Queen’s Family Health Team (in Kingston, Canada) and the person behind the blog DRUGOPINIONS, sharing her experiences with deprescribing as practicing pharmacist in primary care,...
Nursing Home Residents as a Priority Population for Deprescribing
Welcome to our 10th guest blog post. Today Dr. Joshua Niznik of the University of North Carolina will tell us about his work on overtreatment and deprescribing in nursing home residents in the US. Take it away! Nursing Home Residents are a Priority Population for...
Interview #2: Challenges related to deprescribing and conducting (deprescribing) research among care home residents
Hello, deprescribing world! It has been some time since our first interview blog post, so here is a new one: Today we have Dr. Karen Andersen-Ranberg, Consultant Geriatrician at Odense University Hospital and Professor of Geriatric Medicine at the University of...
Guest Blog Post #9: Deprescribing for healthcare students: What do they need to know?
Hello, depriscribers, welcome to another guest blog post! Today we have Dr. Sion Scott from the University of East Anglia (UK) following up with thoughts on the recent blog post regarding healthcare students’ knowledge about deprescribing. Teaching deprescribing A...
Guest Blog Post #8: Facilitating shared decision-making about deprescribing: The perspective of patients, pharmacists and GPs
Hello deprescribers, welcome to our 8th guest blog post. Today we have Dr. Kristie Weir from the University of Sydney summarizing key findings from her recent Ph.D. dissertation that explored preferences around communication and decision-making in deprescribing....
Guest Blog Post #7: To deprescribe or not to deprescribe: Considerations in older adults with polypharmacy during the COVID-19 pandemic
Welcome to our 7th guest blog post. Today, we have Dr. Nagham J. Ailabouni from the University of South Australia writing about deprescribing during the COVID-19 pandemic. Take it away! COVID-19 and older adults The coronavirus disease (COVID-19) pandemic has affected...